Here we aimed to develop a method to predict the presence of NAFLD based on data from subjects enrolled in two separate cohort studies and evaluated whether the involvement of PRL would improve the diagnostic value than previous reported indexes. The gene discussed is PRL; the disease is metabolic dysfunction-associated steatotic liver disease.